Psychiatry and Neurology, Neurology · Munster, IN
NPI
1902095938
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
801 Macarthur Blvd, Suite 404
Munster, IN, 46321
Phone (219) 836-2995
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
2,357 services
Medicare patients, 2024
1,052
Average age 74
Drug cost, 2024
$2.0M
5,138 prescriptions
Company payments, 2025
$2,609
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shaila B Gupta was code 99214 (office e&m - established), 717 times for 489 patients. In total Shaila B Gupta billed 2,357 services in 35 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 717 | 489 | $81.44 | $58K |
| 99232 Hospital E&M - Subsequent | Facility | 301 | 162 | $57.01 | $17K |
| 95886 Electrical Nerve Conductivity | Facility | 189 | 99 | $31.32 | $5,919 |
| 95819 Neurologic | Facility | 151 | 146 | $40.99 | $6,189 |
| 99223 Hospital E&M - Initial | Facility | 150 | 141 | $123.85 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 102 | 67 | $85.89 | $8,761 |
| 95816 Neurologic | Facility | 101 | 99 | $39.21 | $3,960 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 80 | 25 | $22.44 | $1,795 |
| 95911 Electrical Nerve Conductivity | Facility | 70 | 68 | $91.63 | $6,414 |
| 99215 Office E&M - Established | Office | 65 | 62 | $111.35 | $7,238 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 62 | 62 | $10.73 | $665 |
| 99213 Office E&M - Established | Office | 56 | 56 | $61.70 | $3,455 |
| 99205 Office E&M - New | Office | 47 | 47 | $128.48 | $6,038 |
| 99204 Office E&M - New | Office | 40 | 40 | $118.35 | $4,734 |
| 99222 Hospital E&M - Initial | Facility | 39 | 39 | $93.53 | $3,648 |
By year: 2022 $184K for 2,274 services; 2023 $181K for 2,326 services; 2024 $168K for 2,357 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shaila B Gupta prescribed most often to Medicare patients was Gabapentin, with 458 prescriptions and refills. In total Shaila B Gupta wrote 5,138 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 458 | 967 | 141 | $7,332 |
| Memantine Hcl Generic | 406 | 978 | 135 | $11K |
| Levetiracetam Generic | 228 | 544 | 63 | $6,357 |
| Donepezil Hcl Generic | 221 | 588 | 74 | $2,332 |
| Duloxetine Hcl Generic | 175 | 404 | 55 | $4,749 |
| Topiramate Generic | 167 | 381 | 48 | $2,462 |
| Primidone Generic | 166 | 401 | 40 | $3,739 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 163 | 402 | 58 | $3,396 |
| Pregabalin Generic | 158 | 296 | 43 | $6,712 |
| Baclofen Generic | 136 | 285 | 41 | $3,711 |
| Ropinirole Hcl Generic | 116 | 268 | 31 | $2,169 |
| Lamotrigine Generic | 115 | 227 | 21 | $1,117 |
| Alprazolam Generic | 113 | 159 | 33 | $536 |
| Amitriptyline Hcl Generic | 106 | 225 | 32 | $1,584 |
| Lacosamide Generic | 98 | 136 | 20 | $20K |
Brand drugs: 604 claims; generic drugs: 4,493 claims; opioid claims: 127.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shaila B Gupta $2,609 ($2,609 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $897.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 48 | $897 |
| Biogen, Inc. BIIB | 12 | $280 |
| Pfizer Inc. PFE | 10 | $147 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $107 |
| Aucta Pharmaceuticals, Inc. | 5 | $103 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $102 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $72.48 |
| Lundbeck LLC | 3 | $72.05 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $68.97 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $68.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.